As a provider of stem cell products and technologies, you know you need to:
- Make effective product development decisions
- Sell more effectively
- Generate improved revenues
- Take market share
Without strategic guidance on which to base your actions, you’re in a difficult position. New products that don’t sell well are costly mistakes. On the other hand, repeatedly launching high-demand products and skillfully addressing the unmet needs of your clients is certain to position you as a market leader.
In addition, a variety of stem cell types now exist, including mesenchymal stem cells (MSCs), neural stem cells (NSCs), hematopoietic stem cells (HSCs), induced pluripotent stem cells (iPSCs), and more. Furthermore, this portfolio of stem cell types will continue to expand as techniques for stem cell isolation and manipulation continue to improve. This makes product development decisions very difficult, because you have a range of opportunities available to you.
BioInformant’s market intelligence report, “Stem Cell Research Products – Opportunities, Tools, and Technologies” contains information to reduce your confusion and focus your thinking. It identifies the stem cell types that are exhibiting the highest levels of demand within the research community, and it clarifies the end-uses for which stem cell types are most often being applied.
Naturally, when you understand market needs, you can precisely meet them – with minimal cost, risk, and time to market.
A distinctive feature of this report is an end-user survey of 289 researchers that identify stem cells as their research focus. These survey findings reveal stem cell researcher needs, technical preferences, key factors influencing buying decisions, and more. With these insights, you can make smarter decisions, faster.
To profit from this lucrative and rapidly expanding market, you need to understand your key strengths relative to the competition, intelligently position your products to fill gaps in the marketplace, and take advantage of crucial stem cell trends.
View the global strategic report “Stem Cell Research Products – Opportunities, Tools, and Technologies” to get into the minds of your clients today.
About Us
BioInformant is the first and only market research firm to specialize in the stem cell industry. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, Vogue Magazine, and more. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.